203 related articles for article (PubMed ID: 28653969)
21. Breastfeeding, mother-to-child HIV transmission, and mortality among infants born to HIV-Infected women on highly active antiretroviral therapy in rural Uganda.
Homsy J; Moore D; Barasa A; Were W; Likicho C; Waiswa B; Downing R; Malamba S; Tappero J; Mermin J
J Acquir Immune Defic Syndr; 2010 Jan; 53(1):28-35. PubMed ID: 19797972
[TBL] [Abstract][Full Text] [Related]
22. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
23. Fertility and HIV following universal access to ART in Rwanda: a cross-sectional analysis of Demographic and Health Survey data.
Remera E; Boer K; Umuhoza SM; Hedt-Gauthier BL; Thomson DR; Ndimubanzi P; Kayirangwa E; Mutsinzi S; Bayingana A; Mugwaneza P; Koama JB
Reprod Health; 2017 Mar; 14(1):40. PubMed ID: 28292306
[TBL] [Abstract][Full Text] [Related]
24. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
[TBL] [Abstract][Full Text] [Related]
25. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
26. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
28. Cohort profile: the Hlabisa pregnancy cohort, KwaZulu-Natal, South Africa.
Chetty T; Thorne C; Tanser F; Bärnighausen T; Coutsoudis A
BMJ Open; 2016 Oct; 6(10):e012088. PubMed ID: 27798004
[TBL] [Abstract][Full Text] [Related]
29. Exploring fertility decisions among pregnant HIV-positive women on antiretroviral therapy at a health centre in Balaka, Malawi: A descriptive qualitative.
Biseck T; Kumwenda S; Kalulu K; Chidziwisano K; Kalumbi L
Malawi Med J; 2015 Dec; 27(4):128-34. PubMed ID: 26955433
[TBL] [Abstract][Full Text] [Related]
30. PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.
Chagomerana MB; Miller WC; Pence BW; Hosseinipour MC; Hoffman IF; Flick RJ; Tweya H; Mumba S; Chimbwandira F; Powers KA
J Acquir Immune Defic Syndr; 2017 Apr; 74(4):367-374. PubMed ID: 27875363
[TBL] [Abstract][Full Text] [Related]
31. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
[TBL] [Abstract][Full Text] [Related]
32. Supporting Option B+ scale up and strengthening the prevention of mother-to-child transmission cascade in central Malawi: results from a serial cross-sectional study.
Herce ME; Mtande T; Chimbwandira F; Mofolo I; Chingondole CK; Rosenberg NE; Lancaster KE; Kamanga E; Chinkonde J; Kumwenda W; Tegha G; Hosseinipour MC; Hoffman IF; Martinson FE; Stein E; van der Horst CM
BMC Infect Dis; 2015 Aug; 15():328. PubMed ID: 26265222
[TBL] [Abstract][Full Text] [Related]
33. National estimates and risk factors associated with early mother-to-child transmission of HIV after implementation of option B+: a cross-sectional analysis.
Tippett Barr BA; van Lettow M; van Oosterhout JJ; Landes M; Shiraishi RW; Amene E; Schouten E; Wadonda-Kabondo N; Gupta S; Auld AF; Kalua T; Jahn A
Lancet HIV; 2018 Dec; 5(12):e688-e695. PubMed ID: 30467022
[TBL] [Abstract][Full Text] [Related]
34. Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.
Hauser BM; Miller WC; Tweya H; Speight C; Mtande T; Phiri S; Ball LM; Hosseinipour MC; Hoffman IF; Rosenberg NE
Int J STD AIDS; 2018 Feb; 29(2):185-194. PubMed ID: 28750577
[TBL] [Abstract][Full Text] [Related]
35. The relationship between HIV and fertility in the era of antiretroviral therapy in sub-Saharan Africa: evidence from 49 Demographic and Health Surveys.
Marston M; Zaba B; Eaton JW
Trop Med Int Health; 2017 Dec; 22(12):1542-1550. PubMed ID: 28986949
[TBL] [Abstract][Full Text] [Related]
36. Prevention of mother-to-child transmission of HIV Option B+ cascade in rural Tanzania: The One Stop Clinic model.
Gamell A; Luwanda LB; Kalinjuma AV; Samson L; Ntamatungiro AJ; Weisser M; Gingo W; Tanner M; Hatz C; Letang E; Battegay M;
PLoS One; 2017; 12(7):e0181096. PubMed ID: 28704472
[TBL] [Abstract][Full Text] [Related]
37. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
[TBL] [Abstract][Full Text] [Related]
38. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
[TBL] [Abstract][Full Text] [Related]
39. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi.
Weigel R; Hosseinipour MC; Feldacker C; Gareta D; Tweya H; Chiwoko J; Gumulira J; Kalulu M; Mofolo I; Kamanga E; Mwale G; Kadzakumanja A; Jere E; Phiri S
Trop Med Int Health; 2012 Jun; 17(6):751-9. PubMed ID: 22487553
[TBL] [Abstract][Full Text] [Related]
40. An assessment of option B implementation for the prevention of mother to child transmission in Dschang, Cameroon: results from the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) cohort.
Altan AM; Taafo F; Fopa F; Buonomo E; Marazzi MC; Nielsen-Saines K; Orlando S; Scarcella P; Ciccacci F; Mancinelli S; Lio MM; Palombi L
Pan Afr Med J; 2016; 23():72. PubMed ID: 27217896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
